Skip to content

Effects of the Spinomed Active Orthosis on Chronic Back Pain in Women With Vertebral Fractures.

Effects of the Spinomed Active Orthosis on Chronic Back Pain in Women With Osteoporotic Vertebral Bone Fracture and Hyperkyphosis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04854629
Enrollment
80
Registered
2021-04-22
Start date
2021-04-07
Completion date
2022-01-15
Last updated
2022-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kyphosis, Osteopenia

Brief summary

Osteoporotic vertebral fractures often lead to postural changes, chronic spinal pain conditions and limited functionality. Orthoses that straighten the spine have been shown in studies to have a positive effect on pain, posture and the functional state of patients with a fresh vertebral fracture. The planned study investigates the effect of the orthosis Spinomed active in patients aged ≥ 65 years with at least one non-acute osteoporotic vertebral fracture (at least 3 months ago) and chronic back pain.

Interventions

OTHERSpinomed active

Wearing of the orthosis 2-3 h/twice a day for 16 weeks Supplementation of a maximum of 1000 mg/d calcium and 800 IE/d vitamin D

Sponsors

medi GmbH & Co. KG, Bayreuth, Germany
CollaboratorUNKNOWN
University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcomes assessor were unaware of participant status (i.e. spinomed active or control) and were not allowed to ask correspondingly

Intervention model description

Randomized controlled trial with two study groups in parallel: (1) Spinomed active orthosis or 16 weeks (2) non spinomed active orthosis control

Eligibility

Sex/Gender
FEMALE
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Living independently in the community * ≥ 1 low-traumatic vertebral fracture ≥ 3 months ago * Chronic back pain according to the national guideline for low back pain * Mean back pain intensity NPS ≥ 1 (1-10 scale) * Hyperkyphosis, kyphosis angle according to Debrunner \>40° * Intact skin or adequate wound coverage in the area of the contact surface of the orthosis

Exclusion criteria

* Secondary osteoporosis (as determined by study physician) * Expected change in overall pain therapy during the study period * Structurally fixed kyphosis, lack of extension ability of the thoracic spine * Kyphoplasty, vertebroplasty * Use of back orthoses during the last 6 months * Depression * Dementia, cognitive impairment (Mini Mental Test \< 25) * Fresh neurological deficits; incontinence \> grade 1 * Body dimensions that do not allow for adjustment of the back orthosis * Absence during baseline and follow-up assessments

Design outcomes

Primary

MeasureTime frameDescription
Back painAt baseline and after 16 weeks (i.e. over 16 weeks)Change in back pain (mean intensity over 4 weeks on the numeric pain scale (NPS) 0-10).

Secondary

MeasureTime frameDescription
Kyphosis angleAt baseline and after 16 weeks (i.e. over 16 weeks)Changes of kyphosis angle as determined by angle measurement
Functional capacityAt baseline and after 16 weeks (i.e. over 16 weeks)Changes in Chair-Rise-Test
Trunk strength/performanceAt baseline and after 16 weeks (i.e. over 16 weeks)Changes of maximum dynamic trunk strength (index of trunk extension/flexion/lateral flexion) as determined by a dynamic testing device
Everyday life skillsAt baseline and after 16 weeks (i.e. over 16 weeks)Changes of everyday life skills as determined by a questionnaire (late-life function and disability instrument)
Balance capacityAt baseline and after 16 weeks (i.e. over 16 weeks)Changes in Body Sway as determined by a balance sensor device
Pulmonary functionAt baseline and after 16 weeks (i.e. over 16 weeks)Changes in vital capacity as determined by a pulmonary function monitor

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026